Sanofi pushes to accelerate medical writing, reporting processes

By Nick Taylor

- Last updated on GMT

(Eoneren/iStock via Getty Images Plus)
(Eoneren/iStock via Getty Images Plus)

Related tags: Sanofi, Artificial intelligence, Data management, Patient centricity, machine learning, Natural Language Processing

The pharmaceutical company has enlisted the help of the AI and NLP tech specialist to streamline clinical study report generation and submission processes.

Sanofi is looking to scale its natural language generation capabilities with Yseop, positioning it to use its partner’s platform to accelerate the clinical study submission process.

Yseop, a company specializing in artificial intelligence (AI) and natural language processing (NLP), first teamed up with Sanofi four years ago to automate clinical safety reports before expanding its relationship to cover patient narratives. Sanofi is now using the Yseop platform for pharma and vaccine use cases in a push to expedite clinical trial dossier submission workflows.

Generating clinical study reports (CSRs) is a monotonous step before submitting new drugs for approval and often can take weeks or months to produce. Our Augmented Analyst platform helps Sanofi transform data into high-quality narratives and regulatory submission reports, at scale and error-free. Automating CSR writing with our technologies has helped reduce report writing times by an average of 40%​,” said Emmanuel Walckenaer, CEO of Yseop.

Yseop’s augmented medical writer platform is designed to automate report writing, thereby cutting the time it takes to translate data into accurate and consistent specialist medical reports. The company is pitching the technology as a way to save time, resources, and money while removing the risk of manual and human errors in reporting.

While automation is potentially a threat to the employment of humans, Yseop frames its technology as a way to free up medical writers to focus on more valuable and strategic work, rather than a way to replace them with machines. 

Medical writers and their teams face many challenges related to data review and turning insights into reports. Yseop makes what was once a very complex end-to-end process much leaner. Medical writers can then focus on the more complex, nuanced elements of report writing, which require a deeper level of human thought, knowledge, and experience​,” said Walckenaer.

Yseop sees its work with Sanofi as validation of that thinking. By automating two major sections of the CSR, the company reduced the writing time for those parts of the submission by 30%. Yseop recently partnered with Eli Lilly.

Related news

Show more

Related products

show more

Using SDTM, ADaM, and SEND

Using SDTM, ADaM, and SEND

Formedix | 09-Nov-2022 | Technical / White Paper

This article gives an overview of SDTM, ADaM, SEND and ARM, and discusses how these CDISC standards fit in with the wider clinical trial process, and how...

How to design an effective CRF

How to design an effective CRF

Formedix | 10-Oct-2022 | Technical / White Paper

CRFs and eCRFs are used for gathering patient data during clinical trials. They play a crucial role in helping to assess the safety and efficacy of clinical...

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Because When It's On the Line... Capability Matters.

Because When It's On the Line... Capability Matters.

Baxter BioPharma Solutions | 01-Oct-2022 | Product Brochure

Baxter’s BioPharma Solutions business supports leading pharmaceutical companies in meeting their commercialization objectives by providing scientific expertise,...

Related suppliers

Follow us


View more